Companies / Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

Nasdaq: ARWRCIK 879407PASADENA, CAarrowheadpharma.com ↗

Financials · FY2025

Revenue$829.45M
Net income$30.11M
Total debt—
Cash$69.40M
Diluted EPS$-0.01
Shares outstanding141.3M

Ownership

141.3M shares outstanding · as of Jul 30, 2026
3.4%Insiders
Ownership
Insiders3.37%4,753,305
10%+ / strategic14.39%20,323,221
Institutions68.54%96,813,940
Public float13.71%19,364,001

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Anzalone Christopher RichardCEOChief Executive Officer · Director
2.69%3,792,739
O'Brien PatrickCOO
0.39%547,408
Hamilton James CChief Medical Officer
0.17%236,958
Apel Daniel JosephChief Financial Officer
0.12%176,200

Institutional holders 427

View all →
HolderValue% of shares
BlackRock, Inc.$1.21B10.50%
Vanguard Group Inc$1.02B10.83%
Avoro Capital Advisors LLC$705.39M7.52%
State Street Corporation$464.17M4.03%
Fmr LLC$432.89M4.62%
Geode Capital Management, LLC$274.50M3.03%
Slate Path Capital LP$167.54M1.79%
Baker Bros. Advisors LP$124.95M1.41%
Fred Alger Management, LLC$121.69M1.30%
Driehaus Capital Management LLC$117.47M1.25%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon stock$-528.84M-6.5M
-30.43%
14,830,553
10.50% of shares
high
Q1 2026
as of
Norges Bank
13F manager
ExitCommon stock$-113.16M-1.7M
-100.00%
0
high
Q1 2026
as of
Arrowstreet Capital, Limited Partnership
13F manager
TrimCommon stock$-94.10M-1.5M
-71.88%
587,125
0.42% of shares
high
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
AddCommon stock$65.07M+1.0M
+710.49%
1,183,838
0.84% of shares
high
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon stock$65.04M+1.0M
+31.05%
4,278,828
3.03% of shares
high
Q1 2026
as of
Renaissance Technologies LLC
13F manager
NewCommon stock$64.99M+1.0M
1,036,495
0.73% of shares
high
Q2 2026
as of
State Street Corporation
13F manager
TrimCommon stock$-57.81M-709K
-11.07%
5,694,640
4.03% of shares
high
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
AddCommon stock$38.26M+610K
+1510.47%
650,599
0.46% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BlackRock, Inc.Passive13G/A—20,323,221—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ARWR——04280A100—